Bolt biotherapeutics inc.

Major-Pharmaceuticals

BOLT


Executive/
Director

Price

  • Last Close
  • $ 0.58
    $ +0.02 2.65 %
    Dec 6, 2024
  • 52-Week High/Low
  • $1.5 - $0.68
  • YTD
  • -48.2%

  • Trading Volume
  • 18
  • Market Cap Full
  • $ 22M
  • Shares Outstanding
  • 38M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -44.1% 6.9% 25%
Q2 - - - - - - -53% -25.6% -7.9% -6.7%
Q3 - - - - - - -18.2% -27.5% -18.8% -
Q4 - - - - - - -61.3% -12.2% 4.7% -
J F M A M J J A S O N D
2024 -9.8% 12.9% 22.8% - - - - - - - - -
2023 13.1% 9.5% -13.7% 13.7% 8.9% -25.6% 5.5% -18.5% -5.5% -5.8% -13% 31.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-73%-14%-48%

Earnings

2021 2022 2023
Q1 -1.14 -0.64 -0.45
Q2 -0.64 -0.61 -0.48
Q3 -0.63 -0.58 -0.43
Q4 -0.56 -0.53 -
A -3 -2.4 -1.36

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 37.5 37.8
Jun 36.3 37.5 37.8
Sep 37.2 37.6 38
Dec 37.3 37.7 38

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 45 -15.5 -4.1 31 -
Equity multiplier 0.2 0.4 - 0.1 -